177 related articles for article (PubMed ID: 30874618)
1. Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains.
Di Lodovico S; Napoli E; Di Campli E; Di Fermo P; Gentile D; Ruberto G; Nostro A; Marini E; Cellini L; Di Giulio M
Sci Rep; 2019 Mar; 9(1):4646. PubMed ID: 30874618
[TBL] [Abstract][Full Text] [Related]
2. Using next-generation sequencing to analyze Helicobacter pylori clones with different levofloxacin resistances from a patient with eradication failure.
Ye L; Meng F; Mao X; Zhang Y; Wang J; Liu Y; Zhu W; Gu B; Huang Q
Medicine (Baltimore); 2020 Aug; 99(32):e20761. PubMed ID: 32769862
[TBL] [Abstract][Full Text] [Related]
3. New insights into resistance of Helicobacter pylori against third- and fourth-generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations.
Salehi N; Attaran B; Eskini N; Esmaeili M; Sharifirad A; Sadeghi M; Mohammadi M
Helicobacter; 2019 Oct; 24(5):e12628. PubMed ID: 31282059
[TBL] [Abstract][Full Text] [Related]
4. Chemical composition of Pistacia vera L. oleoresin and its antibacterial, anti-virulence and anti-biofilm activities against oral streptococci, including Streptococcus mutans.
Magi G; Marini E; Brenciani A; Di Lodovico S; Gentile D; Ruberto G; Cellini L; Nostro A; Facinelli B; Napoli E
Arch Oral Biol; 2018 Dec; 96():208-215. PubMed ID: 30296655
[TBL] [Abstract][Full Text] [Related]
5. Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.
Wei W; Yang H; Hu L; Ye Y; Li J
J Microbiol Immunol Infect; 2017 Dec; 50(6):821-830. PubMed ID: 26725481
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study.
Ciccaglione AF; Di Giulio M; Di Lodovico S; Di Campli E; Cellini L; Marzio L
J Antimicrob Chemother; 2019 Apr; 74(4):1069-1077. PubMed ID: 30668729
[TBL] [Abstract][Full Text] [Related]
7. Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin.
Lyu T; Cheung KS; Deng Z; Ni L; Chen C; Wu J; Leung WK; Seto WK
Helicobacter; 2023 Aug; 28(4):e12972. PubMed ID: 36965192
[TBL] [Abstract][Full Text] [Related]
8. High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam.
Dang NQH; Ha TMT; Nguyen ST; Le NDK; Nguyen TMT; Nguyen TH; Pham TTH; Tran VH
J Glob Antimicrob Resist; 2020 Sep; 22():620-624. PubMed ID: 32590188
[TBL] [Abstract][Full Text] [Related]
9. Searching for New Tools to Counteract the
Di Fermo P; Di Lodovico S; Amoroso R; De Filippis B; D'Ercole S; Di Campli E; Cellini L; Di Giulio M
Antibiotics (Basel); 2020 Dec; 9(12):. PubMed ID: 33322025
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
[TBL] [Abstract][Full Text] [Related]
11. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
[TBL] [Abstract][Full Text] [Related]
12. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.
Wang LH; Cheng H; Hu FL; Li J
World J Gastroenterol; 2010 May; 16(18):2272-7. PubMed ID: 20458765
[TBL] [Abstract][Full Text] [Related]
13. Biofilm Formation and Antibiotic Resistance Phenotype of
Fauzia KA; Miftahussurur M; Syam AF; Waskito LA; Doohan D; Rezkitha YAA; Matsumoto T; Tuan VP; Akada J; Yonezawa H; Kamiya S; Yamaoka Y
Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32722296
[TBL] [Abstract][Full Text] [Related]
14. Point Mutations at
López-Gasca M; Peña J; García-Amado MA; Michelangeli F; Contreras M
Am J Trop Med Hyg; 2018 Apr; 98(4):1051-1055. PubMed ID: 29405113
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
[TBL] [Abstract][Full Text] [Related]
16. High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam.
Phan TN; Santona A; Tran VH; Tran TN; Le VA; Cappuccinelli P; Rubino S; Paglietti B
Int J Antimicrob Agents; 2015 Mar; 45(3):244-8. PubMed ID: 25499186
[TBL] [Abstract][Full Text] [Related]
17. Molecular detection of H. pylori antibiotic-resistant genes and molecular docking analysis.
Chu A; Wang D; Guo Q; Lv Z; Yuan Y; Gong Y
FASEB J; 2020 Jan; 34(1):610-618. PubMed ID: 31914672
[TBL] [Abstract][Full Text] [Related]
18. Linezolid susceptibility in Helicobacter pylori, including strains with multidrug resistance.
Boyanova L; Evstatiev I; Gergova G; Yaneva P; Mitov I
Int J Antimicrob Agents; 2015 Dec; 46(6):703-6. PubMed ID: 26453146
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of Aloe vera inner gel against Helicobacter pylori strains.
Cellini L; Di Bartolomeo S; Di Campli E; Genovese S; Locatelli M; Di Giulio M
Lett Appl Microbiol; 2014 Jul; 59(1):43-8. PubMed ID: 24597562
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin resistance of Helicobacter pylori strains isolated from patients in southern Poland, between 2006-2012.
Karczewska E; Klesiewicz K; Wojtas-Bonior I; Skiba I; Sito E; Czajecki K; Zwolińska-Wcisło M; Budak A
Acta Pol Pharm; 2014; 71(3):477-83. PubMed ID: 25265828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
